Balaji Amines Q2FY26 Revenue at ¥ 341 Crore, EBITDA at ¥ 67 Crore, Net Profit at ¥ 37 Crore

Balaji Amines Limited, a leading manufacturer of Aliphatic Amines & Speciality Chemicals in India, announced its unaudited financial results for the quarter ended September 30, 2025. The company reported a consolidated revenue of ¥ 341 crore, a 5% decrease from Q1FY26. EBITDA stood at ¥ 67 crore, a 5% increase from Q1FY26 and a 3% decrease from Q2FY25. Net profit stood at ¥ 37.10 crore, a 2% increase from Q1FY26. The company is investing Rs. 750 crores in a phased manner in its subsidiary, Balaji Speciality Chemicals Limited, for a wide range of products including Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN) 30%(Solution), Sodium Cyanide (NaCN) 100%(Solid), Ethylene Diamine Tetra Acetic Acid (EDTA), and Ethylene Diamine Tetra Acetic Acid Disodium Salt(EDTA-2Na). The company is expecting to commission a DME Plant at Unit-IV and N-Methyl Morpholine (NMM) - 5000 TPA during the FY 2025-26 and an improved process based ACN plant during the FY 2026-27. The company remains confident in its ability to harness structural tailwinds and expects a gradual improvement in product mix and pricing realisation over the medium to long term.